These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2428100)

  • 1. Circadian and diurnal variation of circulating immune complexes, complement-mediated solubilization, and the complement split product C3d in rheumatoid arthritis.
    Petersen I; Baatrup G; Brandslund I; Teisner B; Rasmussen GG; Svehag SE
    Scand J Rheumatol; 1986; 15(2):113-8. PubMed ID: 2428100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reflection of disease activity in rheumatoid arthritis by indices of activation of the classical complement pathway.
    Makinde VA; Senaldi G; Jawad AS; Berry H; Vergani D
    Ann Rheum Dis; 1989 Apr; 48(4):302-6. PubMed ID: 2785367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating complement breakdown products in patients with rheumatoid arthritis. Correlation between plasma C3d, circulating immune complexes, and clinical activity.
    Nydegger UE; Zubler RH; Gabay R; Joliat G; Karagevrekis CH; Lambert PH; Miescher PA
    J Clin Invest; 1977 May; 59(5):862-8. PubMed ID: 853126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Serum complement levels in patients with rheumatoid arthritis and vasculitis].
    Tomooka K
    Fukuoka Igaku Zasshi; 1989 Oct; 80(10):456-66. PubMed ID: 2613159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complement C3c and C3d in plasma and synovial fluid in rheumatoid arthritis.
    Berkowicz A; Kappelgaard E; Petersen J; Nielsen H; Ingemann-Hansen T; Halkjaer-Kristensen J; Sørensen H
    Acta Pathol Microbiol Immunol Scand C; 1983 Dec; 91(6):397-402. PubMed ID: 6608857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoclonal antibodies against complement 3 neoantigens for detection of immune complexes and complement activation. Relationship between immune complex levels, state of C3, and numbers of receptors for C3b.
    Aguado MT; Lambris JD; Tsokos GC; Burger R; Bitter-Suermann D; Tamerius JD; Dixon FJ; Theofilopoulos AN
    J Clin Invest; 1985 Oct; 76(4):1418-26. PubMed ID: 2932466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation in rheumatoid arthritis of concentrations of plasma C3d, serum rheumatoid factor, immune complexes and C-reactive protein with each other and with clinical features of disease activity.
    Mallya RK; Vergani D; Tee DE; Bevis L; de Beer FC; Berry H; Hamilton ED; Mace BE; Pepys MB
    Clin Exp Immunol; 1982 Jun; 48(3):747-53. PubMed ID: 6981476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Circulating immune complexes and anti-IgG antibodies in rheumatoid disease. Value of C3d assay].
    Duquesnoy B; Santoro F; Siame JL; Vanhille P; Raviart B; Wattre P; Lemaitre V; Hatron PY
    Rev Med Interne; 1981; 2(1):11-6. PubMed ID: 6972076
    [No Abstract]   [Full Text] [Related]  

  • 9. Steroids reduce complement activation in rheumatoid arthritis.
    Brandslund I; Peters ND; Ejstrup L
    Int J Tissue React; 1985; 7(2):161-5. PubMed ID: 3875589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of plasma C3d and immune complex determinations in the assessment of disease activity of patients with rheumatoid arthritis, systemic lupus erythematosus, and spondylitis ancylopoetica.
    Krauledat PB; Krapf FE; Manger B; Kalden JR
    Rheumatol Int; 1985; 5(3):97-101. PubMed ID: 3892637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complement-mediated solubilization of immune complexes in systemic lupus erythematosus.
    Sakurai T; Fujita T; Kono I; Kabashima T; Yamane K; Tamura N; Kashiwagi H
    Clin Exp Immunol; 1982 Apr; 48(1):37-42. PubMed ID: 6979449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Capacity to solubilize immune complexes in sera and synovial fluids from patients with rheumatoid arthritis.
    Dayer E; Gerster JC; Aguado MT; Lambert PH
    Arthritis Rheum; 1983 Feb; 26(2):156-64. PubMed ID: 6824512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C3 activation products, C3 containing immune complexes, the terminal complement complex and native C9 in patients with rheumatoid arthritis.
    Olmez U; Garred P; Mollnes TE; Harboe M; Berntzen HB; Munthe E
    Scand J Rheumatol; 1991; 20(3):183-9. PubMed ID: 2068540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of classical pathway complement in chronic inflammation. Elevated levels of circulating C3d and C4d split products in rheumatoid arthritis and Crohn's disease.
    Petersen NE; Elmgreen J; Teisner B; Svehag SE
    Acta Med Scand; 1988; 223(6):557-60. PubMed ID: 3389208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The attachment of serum- and plasma-derived C3 to solid-phase immune aggregates and its relation to complement-mediated solubilization of immune complexes.
    Baatrup G; Svehag SE; Jensenius JC
    Scand J Immunol; 1986 Apr; 23(4):397-406. PubMed ID: 3486458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The complement fixing ability of putative circulating immune complexes in rheumatoid arthritis and its relationship to extra-articular disease.
    Bourke BE; Moss IK; Mumford P; Horsfall A; Maini RN
    Clin Exp Immunol; 1982 Jun; 48(3):726-32. PubMed ID: 6981475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Circulating immune complexes-like material and complement in rheumatoid arthritis and ankylosing spondylitis (author's transl)].
    Rodrigo MJ; Gallart MT; Lience E; Arnal C; Sans J
    Med Clin (Barc); 1981 Apr; 76(8):339-46. PubMed ID: 6789016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leucocyte complement receptor 1 (CR1/CD35) transcript and its correlation with the clinical disease activity in rheumatoid arthritis patients.
    Anand D; Kumar U; Kanjilal M; Kaur S; Das N
    Clin Exp Immunol; 2014 Jun; 176(3):327-35. PubMed ID: 24433281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparative study of complement components in polyethylene glycol precipitated immune complexes from patients with ovarian cancer and patients with rheumatoid arthritis.
    Mooney NA; Hay FC; Poulton TA
    Clin Exp Immunol; 1983 Jun; 52(3):561-8. PubMed ID: 6603297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complement activation in bronchial asthma evaluated by the C3d/C3 index.
    Michel O; Sergysels R; Duchateau J
    Ann Allergy; 1986 Dec; 57(6):405-8. PubMed ID: 3491553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.